University Health System: Compassionate Physicians Deliver Advanced Gynecologic Research and Treatment
At University Health System, physicians offer therapies that can benefit patients with complex gynecologic diseases and conditions, making the system a referral hub for the surrounding area. Fueling these treatments are insights gained from leading-edge research and clinical trials...
A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.
On Sept. 5, 2018, the UT Health San Antonio MD Anderson Cancer Center hosted a roundtable discussion with esteemed cancer leaders from UT Health San Antonio and MD Anderson Cancer Center to talk about the impact of cancer in San Antonio and how collaboration in patient care and research is essential to improving not only the outcomes for patients, but how creating a streamlined system of care using proven protocols and processes can best support families and caregivers. These thought leaders and clinicians walked through the rising incidence of the disease in San Antonio. They also laid out plans for how their work together will positively impact patients and their families while focusing on overall cost or “value” of health care spend for this disease that strikes aging and Hispanic populations disproportionately.
Researchers at Lawrence Berkeley National Laboratory (Berkeley Lab) in California have found a link between thirdhand smoke (THS) exposure and lung cancer risk in mice.
More than 7,000 physicians, scientists, investigators and advocates from across the globe will descend on San Antonio the first week in December for the 41st annual San Antonio Breast Cancer Symposium (SABCS).
The prevention and treatment of breast cancer is optimally achieved through a well orchestrated team approach. The Baptist Network for Cancer Care was created more than five years ago to provide Bexar County and South Texas with an efficient and compassionate model to prevent and treat breast cancer. As a result, our Breast Centers have garnered and maintained national recognition and certification of excellence through the National Accreditation Program for Breast Centers (NAPBC).
The risk of developing cancer is not uncommon, since there are nearly 200 diseases of abnormal cell growth. Many cancer research efforts include the promise of improving patient quality of life through multidisciplinary approaches for the continuity of care, yet patients often report...
Immunotherapy is the new frontier in cancer treatment, and researchers at START are at the forefront. START is one of the largest Phase 1 clinical trial organizations in the world.
A patient says Baptist Health System’s navigator helped her find ‘new normal.’
The Mays Cancer Center at UT Health San Antonio is hosting the Best of ASCO Texas Review at the Omni La Mansion Del Rio on San Antonio’s famous Riverwalk.
- 1 of 3
- next ›